Skip to main content
. 2022 Sep 17;13:5466. doi: 10.1038/s41467-022-33146-7

Fig. 1. Consort diagram of study design.

Fig. 1

A diagram showing trial groups and participant flow in the study (NCT05054621). Participants were randomly assigned to receive either a heterologous boost of MVC-COV1901 or a homologous booster dose of ChAdOx1. There was one screen failure (participant S30017 was unable to visit the study site in the scheduled time points) in the trial.